Compare McKesson Corporation (MCK) vs Tyson Foods, Inc. (TSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Tyson Foods, Inc. — how do they compare? McKesson Corporation trades at $930 (market cap $108.46B), while Tyson Foods, Inc. trades at $52.29 (market cap $18.41B). The key difference: McKesson Corporation is far larger — about 5.9× Tyson Foods, Inc.'s market cap, and Tyson Foods, Inc. pays the higher dividend (3.9%). Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Tyson Foods, Inc. for 76 Days on average.
| MCK | TSN | |
|---|---|---|
Market Cap | $108.46B | $18.41B |
Volume | 712,607 | 3,757,599 |
Sector | Health | Consumer Staples |
52-Week High | $995.69 | $68.75 |
52-Week Low | $725.17 | $50.47 |
Typical Hold Time | 74 Days | 76 Days |
Enterprise Value | $115.00B | $25.68B |
Dividend Yield | 0.4% | 3.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $910.33, down 1.23% today, but maintains strong analyst support with 80.65% buy ratings and a $956.43 consensus price target. The stock shows bullish technical momentum with recent earnings beats and a major distribution agreement extension with CVS Health through 2032. Revenue growth has accelerated from $264B in 2022 to $359B in 2025, though net margins remain thin at 1.12%.
MCK presents a compelling growth story with consistent earnings outperformance and strategic partnerships driving long-term visibility. However, investors face risks from margin compression, drug pricing pressures, and high leverage with negative shareholder equity. The current valuation at 24.42x P/E appears reasonable given the company's market leadership and oncology growth prospects.
Tyson Foods (TSN) trades at $51.70, down 0.52% on the day, with mixed technical signals showing neutral overall but bearish moving averages. The company reported Q2 2026 EPS of $0.99, beating expectations of $0.989, though revenue growth remains modest at 1.5%-2.0% for fiscal 2026. Valuation metrics show a P/E of 31.91 and P/S of 0.33, with analyst consensus price target at $65.40 representing 26% upside potential.
The stock presents a cautious opportunity with strong analyst support (53% buy ratings) but faces headwinds from beef segment losses and ongoing securities investigations. Upside potential exists if management can stabilize margins and execute on cost controls, though investors should monitor the Q4 earnings release on November 16, 2026 for confirmation of turnaround progress.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Tyson Foods, Inc.
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →
